Supply of the medicinal product INN Metreleptin, trade name Myalepta, in accordance with Regulation 10/2011

This tender concerns the supply of a specific medicinal product, identified by its International Nonproprietary Name (INN) as Metreleptin and its trade name as Myalepta. The procurement process will be conducted in accordance with the provisions of Regulation 10/2011. This regulation likely outlines the specific procedures, requirements, and legal framework governing the acquisition of pharmaceutical products within the relevant jurisdiction. The tender is expected to detail the quantities required, delivery timelines, quality standards, and any specific packaging or storage instructions for Metreleptin. Potential bidders, typically pharmaceutical manufacturers or authorized distributors, will need to demonstrate their capacity to meet these specifications and comply with all regulatory stipulations. The objective is to ensure the consistent and reliable availability of this essential medication. Further details regarding the tender, including the exact scope of work, eligibility criteria for bidders, submission deadlines, and evaluation methodology, are anticipated to be provided in the full tender documentation. Interested parties are advised to carefully review all issued documents to ensure full compliance and to submit a competitive proposal. This procurement is crucial for maintaining healthcare services that rely on the availability of Metreleptin.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.